Progress and Challenges of Messenger RNA Vaccines in the Therapeutics of NSCLC.

Cancers (Basel) · 2023 · PMC10705317 · PMID 38067293

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

A notable trend in preclinical research can be observed with the aim of identifying suitable antigens specifically for the NSCLC subtypes of adenocarcinoma and squamous carcinoma [ 36 , 37 , 38 ].

also in 2,135 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.